1. Clinico-Pathological Importance of miR-146a in Lung Cancer
   Javaid Ahmad Wani et al, 2021, Diagnostics CrossRef
2. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
   Julija Simiene et al, 2023, BMC Cancer CrossRef
3. Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
   Chin Fung Kelvin Kan et al, 2021, Frontiers in Oncology CrossRef
4. Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer
   Carlos Pérez-Sánchez et al, 2021, Journal of Personalized Medicine CrossRef
5. Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy
   Ziyu Jiang et al, 2022, Journal of Nanomaterials CrossRef
6. MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
   Javaid Ahmad Wani et al, 2022, Diagnostics CrossRef
7. Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy
   Vladimir I. Vashchenko et al, 2021, Reviews on Clinical Pharmacology and Drug Therapy CrossRef